SEC Form 4 · accession 0001144204-17-007173
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Rice
Officer — President & CEO · Director
Period of report
Feb 7, 2017
Accepted (ET)
Feb 9, 2017 · 7:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.78 | Feb 7, 2017 | A | 100,000 | A | — | Feb 17, 2022 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The options vest 25% on the first anniversary of the grant date and thereafter, in 36 equal monthly installments.